Levine Cancer Center

The trials here

What the 10 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials
• Lung cancer2 trials
• Melanoma2 trials
• Pancreatic cancer2 trials
• Acute myeloid leukaemia1 trial
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• and 3 more

Phase

• Phase 1/25 trials
• Phase 33 trials
• Phase 11 trial

Status

• Active, not recruiting4 trials
• Terminated3 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Genmab3 trials
• Actuate Therapeutics Inc.1 trial
• BeOne Medicines1 trial
• Caribou Biosciences, Inc.1 trial
• Immuneering Corporation1 trial
• and 3 more

Running trials

• Recruiting

  Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  NCT07214779· Phase 3· Incyte Corporation· Source

• Recruiting

  A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

  NCT06943872· Phase 3· BeOne Medicines· Source

  Contact: Study Director

• Recruiting

  A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT05730036· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Active, not recruiting

  A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

  NCT05585320· Phase 1/2· Immuneering Corporation· Source

• Enrolling by invitation

  Long-Term Follow-up Study

  NCT05332054· Caribou Biosciences, Inc.· Source

• Active, not recruiting

  Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)

  NCT04663347· Phase 1/2· Genmab· Source

• Active, not recruiting

  GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

  NCT04083599· Phase 1/2· Genmab· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Multiple myeloma1 recruiting
• Ovarian cancer1 recruiting

Closed trials

• Terminated

  Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

  NCT05721222· Phase 1/2· Genmab· Source

• Terminated

  9-ING-41 in Pediatric Patients With Refractory Malignancies.

  NCT04239092· Phase 1· Actuate Therapeutics Inc.· Source

• Terminated

  A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT03215030· Phase 1/2· Teva Branded Pharmaceutical Products R&D LLC· Source